Steve Ley group

Regulation of gene expression in immune responses by NF-κB and MAP kinases

Following infection, pathogenic microorganisms such as viruses and bacteria are initially recognised by specific receptors on the surface of neutrophils and macrophages. This triggers an immediate ‘innate’ immune response involving the production of proteins called chemokines and cytokines. These attract other immune cells to the sites of infection and also initiate the adaptive immune response that culminates in the production of protective antibodies and killing of infected cells.

Coordinating the expression of genes that control innate and adaptive immune responses involves activation of the NF-κB family of transcription factors and the ERK MAP kinase signalling enzyme. We study a signalling pathway that regulates both NF-κB and ERK MAP kinase activation by inducing proteolysis of the inhibitory protein NF-κB1 p105. We have recently found that p105 regulation of NF-κB is critical for the function of CD4 T cells during an immune response. Our current studies aim to determine whether blockade of p105 proteolysis might be useful for the treatment of specific autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

Click image to view at full-size

Regulation of NF-κB and ERK activation in innate immune responses.

Selected publications

Ley group

Dr Steve Ley

Steve Ley
+44 (0)20 8816 2463

Recent publications

Ley biography

Our research themes

Click links to view others working on these themes

Top of page

© MRC National Institute for Medical Research
The Ridgeway, Mill Hill, London NW7 1AA